Akira Inoue - Publications

Affiliations: 
Neurosurgery Yamagata University, Yamagata-shi, Yamagata-ken, Japan 

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Itadani S, Yashiro K, Aratani Y, Sekiguchi T, Kinoshita A, Moriguchi H, Ohta N, Takahashi S, Ishida A, Tajima Y, Hisaichi K, Ima M, Ueda J, Egashira H, Sekioka T, ... ... Inoue A, et al. Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma. Journal of Medicinal Chemistry. 58: 6093-113. PMID 26200813 DOI: 10.1021/acs.jmedchem.5b00741  0.379
2015 Itadani S, Takahashi S, Ima M, Sekiguchi T, Aratani Y, Egashira H, Matsumura N, Inoue A, Yonetomi Y, Fujita M, Nakayama Y, Takeuchi J. Discovery of a potent, orally available dual CysLT₁ and CysLT₂ antagonist with dicarboxylic acid. Bioorganic & Medicinal Chemistry. 23: 2079-97. PMID 25800431 DOI: 10.1016/j.bmc.2015.03.011  0.367
2015 Narumi S, Miki Y, Hata S, Ebina M, Saito M, Mori K, Kobayashi M, Suzuki T, Iwabuchi E, Sato I, Maemondo M, Endo C, Inoue A, Kondo T, Yamada-Okabe H, et al. Anterior gradient 2 is correlated with EGFR mutation in lung adenocarcinoma tissues. The International Journal of Biological Markers. 30: e234-42. PMID 25634032 DOI: 10.5301/jbm.5000131  0.442
2015 Itadani S, Yashiro K, Aratani Y, Sekiguchi T, Kinoshita A, Moriguchi H, Ohta N, Takahashi S, Ishida A, Tajima Y, Hisaichi K, Ima M, Ueda J, Egashira H, Sekioka T, ... ... Inoue A, et al. Discovery of Gemilukast (ONO-6950), a Dual CysLT1 and CysLT2 Antagonist As a Therapeutic Agent for Asthma Journal of Medicinal Chemistry. 58: 6093-6113. DOI: 10.1021/acs.jmedchem.5b00741  0.342
2014 Kamata M, Okitsu Y, Fujiwara T, Kanehira M, Nakajima S, Takahashi T, Inoue A, Fukuhara N, Onishi Y, Ishizawa K, Shimizu R, Yamamoto M, Harigae H. GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cells. Haematologica. 99: 1686-96. PMID 25150255 DOI: 10.3324/Haematol.2014.105692  0.343
2014 Inoue A, Akita H, Eguchi H, Hama N, Wada H, Kawamoto K, Kobayashi S, Mori M, Doki Y, Nagano H. Gastric conduit-preserving, radical pancreaticoduodenectomy with microvascular reconstruction for pancreatic head cancer after esophagectomy: report of a case. Surgery Today. 44: 786-91. PMID 24264060 DOI: 10.1007/s00595-013-0791-2  0.359
2012 Kobayashi M, Miki Y, Ebina M, Abe K, Mori K, Narumi S, Suzuki T, Sato I, Maemondo M, Endo C, Inoue A, Kumamoto H, Kondo T, Yamada-Okabe H, Nukiwa T, et al. Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinoma. British Journal of Cancer. 107: 1745-53. PMID 23099808 DOI: 10.1038/bjc.2012.422  0.454
2012 Ishima Y, Hara M, Kragh-Hansen U, Inoue A, Suenaga A, Kai T, Watanabe H, Otagiri M, Maruyama T. Elucidation of the therapeutic enhancer mechanism of poly-S-nitrosated human serum albumin against multidrug-resistant tumor in animal models. Journal of Controlled Release : Official Journal of the Controlled Release Society. 164: 1-7. PMID 23063551 DOI: 10.1016/j.jconrel.2012.10.003  0.357
2012 Ohue S, Kohno S, Inoue A, Yamashita D, Harada H, Kumon Y, Kikuchi K, Miki H, Ohnishi T. Accuracy of diffusion tensor magnetic resonance imaging-based tractography for surgery of gliomas near the pyramidal tract: a significant correlation between subcortical electrical stimulation and postoperative tractography. Neurosurgery. 70: 283-93; discussion 2. PMID 21811189 DOI: 10.1227/NEU.0b013e31823020e6  0.36
2006 Ishimoto O, Sugawara S, Inoue A, Ishida T, Munakata M, Koinumaru S, Hasegawa Y, Suzuki T, Miki H, Saijo Y, Nukiwa T. Phase II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 1: 979-83. PMID 17409982  0.432
Show low-probability matches.